TGFB1 and neoplasm: The increased expression of TNF-α in CD4+ T cells was also compounded with a significant decrease in the expression of inhibitory cytokine TGF-β in the combinatorial treatment of CT26 tumor cells when compared to single agents further confirming the immune stimulation (Supplementary Figure 5).